These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1693342)

  • 41. Sex and drugs in Schistosoma mansoni.
    Mattoccia LP; Lelli A; Cioli D
    J Parasitol; 1982 Apr; 68(2):347-9. PubMed ID: 6176705
    [No Abstract]   [Full Text] [Related]  

  • 42. Repair in vivo of liver deoxyribonucleic acid damaged by hycanthone and related compounds.
    Sarma DS; Zubroff J; Rajalakshmi S
    Mol Pharmacol; 1977 Jul; 13(4):719-25. PubMed ID: 887075
    [No Abstract]   [Full Text] [Related]  

  • 43. Schistosomicides and DNA functioning.
    Pica-Mattoccia L; Cioli D; Archer S
    Biochem Soc Trans; 1987 Feb; 15(1):70-3. PubMed ID: 3556742
    [No Abstract]   [Full Text] [Related]  

  • 44. Combined treatment of Biomphalaria glabrata infected by Schistosoma mansoni with oxamniquine and praziquantel: Reproductive histological and metabolic aspects.
    Lima RN; Coelho PMZ; Mattos ACA; Mello Silva CC; Augusto RC; Mota EM; de Souza S; Atella GC; Cabral SS; Gabriel Kluck GE; Faro MJ
    Exp Parasitol; 2017 Dec; 183():6-12. PubMed ID: 29017937
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of hycanthone and maleic hydrazide on the frequency of micronuclei in the bone-marrow erythrocytes of mice.
    Chaubey RC; Kavi BR; Chauhan PS; Sundaram K
    Mutat Res; 1978 May; 57(2):187-91. PubMed ID: 351389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticholinergic properties of the antischistosomal drug hycanthone.
    Hillman GR; Senft AW
    Am J Trop Med Hyg; 1975 Sep; 24(5):827-34. PubMed ID: 1190369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modification of cytochrome P-450, NADPH-cytochrome c reductase and aryl hydrocarbon hydroxylase activities by schistosomicidal drugs.
    Mostafa MH; Swelem SM; Farag HF
    Biochem Pharmacol; 1989 Jan; 38(2):251-5. PubMed ID: 2492425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oxamniquine in the prevention of bilharzial infection.
    Jewsbury JM
    Cent Afr J Med; 1977 Nov; 23(11 Suppl):18-20. PubMed ID: 606372
    [No Abstract]   [Full Text] [Related]  

  • 49. Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/oxamniquine-resistant strains are mutated in the same gene.
    Pica-Mattoccia L; Dias LC; Moroni R; Cioli D
    Exp Parasitol; 1993 Dec; 77(4):445-9. PubMed ID: 8253157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of Schistosoma mansoni infection, and of oxamniquine, a new antischistosomal drug on some vitamins in the livers of hamsters.
    Saleh S; Shehata M
    Pol J Pharmacol Pharm; 1979; 31(6):555-61. PubMed ID: 550116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
    Bonesso-Sabadini PI; de Souza Dias LC
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of 700 cases of bilharziasis with the new drugs oxamniquine, oltipraz, praziquantel].
    Lapierre J; Keita A; Faurant C; Heyer F; Tourte-Schaefer C; Ancelle T; Dupouy-Camet J
    Bull Soc Pathol Exot Filiales; 1983 Nov; 76(5):526-33. PubMed ID: 6673843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Action of antischistosomal drugs, hycanthone and its analog 1A-4 N-oxide, on viral interferon induction.
    Hahon N; Ong T
    J Toxicol Environ Health; 1980 Jul; 6(4):705-12. PubMed ID: 6158576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proceedings: Evaluation of the mutation spectrum induced by hycanthone in Drosophila melanogaster; mutagenicity of hycanthone analogues.
    Kramers PG; Knaap AG
    Mutat Res; 1975 Aug; 29(2):251-2. PubMed ID: 810714
    [No Abstract]   [Full Text] [Related]  

  • 55. Early steps in mutagenesis by hycanthone.
    Bases R; Mendez F; Elequin F; Liebeskind D; Kozin A; Neubort S
    Cancer Res; 1978 Mar; 38(3):781-6. PubMed ID: 626982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimuscarinic activities of hycanthone analogs: possible relationship with animal toxicity.
    Gordon RK; Chiang PK
    J Pharmacol Exp Ther; 1986 Jan; 236(1):85-9. PubMed ID: 3484525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical and pharmacological effects in relation to the mode of action of antischistosomal drugs.
    Woolhouse NM
    Biochem Pharmacol; 1979 Aug; 28(16):2413-8. PubMed ID: 41528
    [No Abstract]   [Full Text] [Related]  

  • 58. Hycanthone resistance in schistosomes correlates with the lack of an enzymatic activity which produces the covalent binding of hycanthone to parasite macromolecules.
    Pica-Mattoccia L; Archer S; Cioli D
    Mol Biochem Parasitol; 1992 Oct; 55(1-2):167-75. PubMed ID: 1435868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental chemoprophylaxis against schistosomiasis. II. Stage I comparison of lucanthone, hycanthone, niridazole and oxamniquine (UK 4271).
    Jewsbury JM
    Ann Trop Med Parasitol; 1973 Dec; 67(4):431-8. PubMed ID: 4787715
    [No Abstract]   [Full Text] [Related]  

  • 60. [A human strain of Schistosoma mansoni resistant to schistosomicides].
    Dias LC; Pedro RJ; Rigo E; Goto MM; Mafra GL
    Rev Saude Publica; 1978 Mar; 12(1):110. PubMed ID: 675134
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.